(Q38121484)

29 August 2017

title

MicroRNAs in heart failure: new targets in disease management (English)

1 reference

29 August 2017

0 references

1 reference

I Elzenaar

1

1 reference

29 August 2017

Y M Pinto

series ordinal

2

1 reference

29 August 2017

R J van Oort

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

12 July 2013

1 reference

Clinical Pharmacology & Therapeutics

29 August 2017

published in

1 reference

29 August 2017

volume

94

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

480-489

1 reference

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Role of microRNAs in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs play an essential role in the development of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miRNA expression in the failing human heart: functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

A deep sequencing approach to uncover the miRNOME in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs in control of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNAs: new players in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Small changes can make a big difference - microRNA regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Control of stress-dependent cardiac growth and gene expression by a microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Non-cardiomyocyte microRNAs in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-24 regulates cardiac fibrosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-24 regulates vascularity after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Role of RyR2 phosphorylation at S2814 during heart failure progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Mir-24 regulates junctophilin-2 expression in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Therapeutic use of microRNAs in myocardial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

Altered microRNA expression in human heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.138

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2013.138

1 reference

Dimensions Publication ID

29 August 2017

1012576005

0 references

1 reference